Clinical trial Recruiting at 1 site Interventional Ages 19 and up

Using stem cells to repair large rotator cuff tears

Official title: Arthroscopic Rotator Cuff Repair with Umbilical Cord-derived Mesenchymal Stem Cells for Large to Massive Rotator Cuff Tears

Run by Korea University Anam Hospital · NCT06817616 · Data updated 2026-11-12

This study is testing whether injections of stem cells from umbilical cords can help people with large rotator cuff tears recover better after surgery.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment15 (estimated)
SponsorKorea University Anam Hospital
Academic / other
Locations1 site (Seoul, Korea)
StatusRecruiting
StartedJanuary 17, 2025
Main results expectedApril 2026
Study endsApril 2026
Registry record updatedFebruary 18, 2025
Trial IDNCT06817616 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 19 and older with unilateral shoulder pain and extensive rotator cuff tears that have not responded to standard treatments.

Probably not a fit

Patients with small or medium rotator cuff tears or those who have had recent shoulder surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the safety of using allogeneic umbilical cord-derived mesenchymal stem cells (UC-MSCs) in patients undergoing arthroscopic repair for large to massive rotator cuff tears. Participants must be experiencing significant shoulder pain and have not found relief from conventional treatments. The study aims to assess the effectiveness of stem cell injections in enhancing recovery and healing in these patients. The trial is focused on individuals with confirmed extensive rotator cuff injuries as diagnosed by imaging techniques.

Why it matters

Potential benefit: If successful, this approach could lead to improved healing and recovery for patients with large rotator cuff tears.

How similar studies have gone: While the use of stem cells in orthopedic applications is gaining interest, this specific approach for rotator cuff repair is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female 19 years of age and older
* Unilateral shoulder pain with a pain score of 4 or higher.
* patients with a symptom duration of at least three months who have not responded to conventional treatments, including analgesics.
* patients diagnosed with massive or extensive full-thickness rotator cuff tears confirmed by computed tomography arthrography or magnetic resonance imaging.

Exclusion Criteria:

* patients diagnosed with small or medium full-thickness rotator cuff tears among study participants with full-thickness rotator cuff tears.
* patients who have received subacromial injection therapy in the affected shoulder within the past three months.
* patients who have undergone rotator cuff surgery on the affected shoulder within the past six months.
* patients exhibiting or suspected of having the following radiological findings: malignant tumors, severe glenohumeral osteoarthritis, or bony abnormalities causing subacromial space narrowing.
* patients presenting with symptomatic cervical spine disorders.
* patients experiencing bilateral shoulder pain.
* patients diagnosed with multiple arthritis, infectious arthritis, rheumatoid arthritis, or fibromyalgia.
* patients with neurological deficits.
* Pregnant or breastfeeding patients
* patients unwilling to use effective contraception during the study period.
* patients currently infected with HBV, HCV, or HIV, or those with a positive RPR test result.
* patients with severe conditions that may affect the study, including cardiovascular diseases, renal diseases, hepatic diseases, endocrine disorders, or malignancies.
* patients who are unable to comprehend the questionnaires used for study assessments, including the Visual Analog Scale (VAS), or those with communication difficulties due to psychiatric disorders.
* Any other cases deemed inappropriate for study participation by the investigator.

Where it's running

  • Korea University Anamh Hospital
    Seoul, Korea, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.